Clinical trials

Filters
Clear filters
1,718 trials
TrialSponsorPhaseStatusPrimary completion
Multiple Doses and Regimens of Cabozantinib in Subjects With Grade IV Astrocytic Tumors in First or Second RelapseNCT01068782ExelixisPhase 2Terminated2011-05Actual
Efficacy of To Be Marketed (TBM) Cholic Acid Capsules Used to Treat Children With Inborn Errors of Bile Acid SynthesisNCT01115582MIRMPhase 3Completed2010-08Actual
PDA001 for the Treatment of Adults With Moderate-to-Severe Crohn's DiseaseNCT01155362Celularity IncorporatedPhase 2Completed2012-02Actual
VA-006 Vaccinia Vaccine (ACAM2000) for the Production of VIGIVNCT01158157Emergent BioSolutionsPhase 3Completed2012-02-14Actual
Evaluation of the Tympanostomy Tube Delivery SystemNCT01202578Integra LifeSciences CorporationPhase 2, Phase 3Completed2010-11Actual
Safety Study of Tasimelteon for Treatment of Non-24-Hour-Sleep-Wake Disorder in Blind Individuals With No Light PerceptionNCT01218789Vanda PharmaceuticalsPhase 3Unknown2024-12-05Estimated
Study on the Anti-tumor Activity, Safety and Pharmacology of IPH2101 in Patients With Smoldering Multiple MyelomaNCT01222286Innate PharmaPhase 2Completed2012-07Actual
Evaluation of PROCHYMAL® for Treatment-refractory Moderate-to-severe Crohn's DiseaseNCT01233960Mesoblast, Inc.Phase 3Completed2014-09-15Actual
Open Label Study With Imetelstat to Determine Effect of Imetelstat in Patients w/ Previously Treated Multiple MyelomaNCT01242930Geron CorporationPhase 2Completed2014-11Actual
Study of Ataluren in Previously Treated Participants With Nonsense Mutation Dystrophinopathy (nmDBMD)NCT01247207PTC TherapeuticsPhase 3Terminated2026-02-10Actual
Galinpepimut-S (WT-1 Analog Peptide) Vaccine in Malignant Pleural Mesothelioma After Combined Modality TherapyNCT01265433Sellas Life Sciences GroupPhase 2Completed2016-11-30Actual
WT1 Vaccine Treatment of Patients in Remission From Acute Myeloid Leukemia (AML) or Acute Lymphoblastic Leukemia (ALL)NCT01266083Sellas Life Sciences GroupPhase 2Completed2016-09-30Actual
Relapse Prevention Study in Patients With SchizophreniaNCT01291511Vanda PharmaceuticalsPhase 3Completed2014-03Actual
Hepatitis B Virus Antibody Booster Program for the Production of Hepatitis B Immune Globulin (HBIG)NCT01311674Emergent BioSolutionsPhase 3Terminated2011-03-11Actual
Phase 3 Study of ProstAtak® Immunotherapy With Standard Radiation Therapy for Localized Prostate CancerNCT01436968CADLPhase 3Active not recruiting2024-08Actual
Open Label, Continuation Study of Cholic Acid in Subjects With Inborn Errors of Bile Acid SynthesisNCT01438411MIRMPhase 3Completed2016-07Actual
RP5063 in Subjects With Schizophrenia or Schizoaffective DisorderNCT01490086Reviva PharmaceuticalsPhase 2Completed2013-03Actual
Immunogenicity and Safety Study of a Three-Dose BioThrax® Regimen for Post-Exposure Prophylaxis in Healthy AdultsNCT01491607Emergent BioSolutionsPhase 3Completed2012-05Actual
Preliminary Efficacy and Safety of INNO-206 Compared to Doxorubicin in Advanced Soft Tissue SarcomaNCT01514188IBRXPhase 2Completed2014-04-09Actual
Pilot Phase 2 Study to Investigate the Preliminary Efficacy and Safety of INNO-206 in Advanced Pancreatic CancerNCT01580397IBRXPhase 2Completed2013-05-13Actual
Randomized, Double-Blind, Safety and Efficacy Study of RE-021 (Sparsentan) in Focal Segmental GlomerulosclerosisNCT01613118TVTXPhase 2Completed2016-06Actual
A Multinational, Randomized, Open-Label Study of Custirsen In Patients With Advanced or Metastatic (Stage IV) Non-Small Cell Lung CancerNCT01630733Achieve Life SciencesPhase 3Completed2016-11-17Actual
Adenoviral Vector Monotherapy or Combination With Chemotherapy in Subjects With Recurrent/Metastatic Breast Cancer.NCT01703754Alaunos TherapeuticsPhase 2Terminated2014-08-07Actual
Phase 2 Study to Evaluate Safety and Efficacy of RM-493 in Obese ParticipantsNCT01749137RYTMPhase 2Completed2013-09-28Actual
Ciprofloxacin BioThrax Co-Administration StudyNCT01753115Emergent BioSolutionsPhase 2Completed2013-08Actual
A Phase 2 Safety and Immunogenicity Study for an Anthrax Vaccine Using 3 Schedules and Two Dose LevelsNCT01770743Emergent BioSolutionsPhase 2Completed2014-02Actual
Comparison of Processed Nerve Allograft and Collagen Nerve Cuffs for Peripheral Nerve RepairNCT01809002Axogen CorporationPhase 3Completed2021-08-30Actual
Phase 2 Study of the Monoclonal Antibody MGAH22 (Margetuximab) in Patients With Relapsed or Refractory Advanced Breast CancerNCT01828021MacroGenicsPhase 2Completed2016-12-07Actual
Phase IIa Study Evaluating Safety and Efficacy of BL-8040 in Relapsed/Refractory AML PatientsNCT01838395BLRXPhase 2Completed2016-03Actual
Basket Study of Neratinib in Participants With Solid Tumors Harboring Somatic HER2 or EGFR Exon 18 MutationsNCT01953926PBYIPhase 2Terminated2023-01-02Actual

Primary completion marks the end of data collection for the main study measures, not a results publication date.